NHRF Online Seminars / Institute of Chemical Biology “Metabolomics-based studies for the discovery of disease biomarkers in human biospecimens and animal models” Dr. Olga Deda, Biochemist-Biotechnologist, PhD Analytical Chemistry, Post-doctoral Researcher, Laboratory of Forensic Medicine and Toxicology, School of Medicine, Aristotle University of Thessaloniki, Greece / Post-doctoral Research Fellow at State Scholarships Foundation/ IKY- Greece 12.00-12.30 EET Athens // Zoom Meeting
Zoom Link: https://us06web.zoom.us/j/86264438677?pwd=WnRUNHV6WVdVSUdoSGxhcmNOMXVMUT09 Meeting ID: 862 6443 8677 // Passcode: 211298
NHRF Online Seminars / Institute of Chemical Biology “Integration of omics datasets with clinical information for improving patient management: application in bladder cancer and multiple myeloma” Dr. Ieronymos Zoidakis, Senior Research Scientist, Proteomics Facility, Biomedical Research Foundation, Academy of Athens 12.00-12.30 EET Athens // Zoom Meeting
NHRF Online Seminars / Institute of Chemical Biology “Determination of protein structure and dynamics by combining molecular simulation with CryoEM data” Z. Faidon Brotzakis, Centre of Misfolding Disease, Department of Chemistry, University of Cambridge. 12.00-12.40 EET Athens // Zoom Meeting “The implication of Platelet activating factor in inflammation-related chronic disorders and the potential benefits of dietary bioactive polar lipids” Dr. Alexandros Tsoupras, Lecturer, Department of Biological Sciences, University of Limerick, Ireland. 12.40-13.10 EET Athens // Zoom Meeting
NHRF Online Seminars / Institute of Chemical Biology “Computational bridges between Structural and Network-based Systems Biology” Dr. Christos T. Chasapis, Senior Researcher, NMR facility, School of Natural Sciences, University of Patras and Institute of Chemical Engineering Sciences (ICE-HT), FORTH, Patras 12.00 EET Athens // Zoom Meeting
3rd Newsletter of the European Project “EuroNeurotrophin” funded under the EU’s Horizon 2020 programme H2020-MSCA-ITN-2017 “EuroNeurotrophin” «A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation»
“RESEARCH CREATE-INNOVATE” 2ND CYCLE The National Hellenic Research Foundation currently participates in the research project ΒΙΟΚΑRΕΤRΑ "Identification of genomic and transcriptomic prognostic bio-signatures in head and neck cancer". The BIOKARETRA project is in the context of translational research that aims to identify and validate prognostic and predictive biomarkers for head and neck cancer.
Newsletters and other news of the European Project “EuroNeurotrophin” funded under the EU’s Horizon 2020 programme H2020-MSCA-ITN-2017 “EuroNeurotrophin” «A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation». The EU-funded project EuroNeurotrophin, is the first European consortium to study small molecule neurotrophin mimetics in depth, and in order to progress their clinical translation will build the research capacity necessary for the development of novel candidate therapies. The National Hellenic Research Foundation (NHRF), Institute of Chemical Biology (ICB), coordinates “EuroNeurotrophin” under the supervision of ICB Research Director and Project Coordinator, Dr Theodora Calogeropoulou. https://www.euroneurotrophin.eu/
“RESEARCH-CREATE-INNOVATE” The National Hellenic Research Foundation currently participates in the research project CLOUDSCREEN that aims to develop a new generation "one-stop-shop- platform (CloudScreen) for drug repositioning and repurposing in precision medicine. Combining the reasoning skills of artificial and human intelligence, the platform empowers efficacy and toxicity prediction, evaluation, and validation for the repurposed drugs.
“RESEARCH-CREATE-INNOVATE” The National Hellenic Research Foundation participates in the research project DINNESMIN that aims to the pre-clinical development of innovative neuroprotective & neuroregenerative synthetic micro-neurotrophins for the treatment of Alzheimer Disease.
“RESEARCH-CREATE-INNOVATE” The National Hellenic Research Foundation participates in the research project PEPtADe that aims to develop potent small molecules-inhibitors of Aβ aggregation, which plays a key role in the progression of Alzheimer's disease (AD).
Advanced Research on the 3D Structure of Mosquito Odorant Receptor Coreceptor (3D-ORCO) The research project “Advanced Research on the 3D Structure of the Mosquito Odorant Receptor Coreceptor (3D-ORCO)” which is coordinated by the National Hellenic Research Foundation and Dr. Spyros Zographos, on behalf of the Institute of Chemical Biology (ICB/NHRF), was among the 22 Category II proposals in the area of “Life Sciences - Medical and Health Sciences”, funded by the Hellenic Foundation for Research and Innovation H.F.R.I. (ELIDEK) in the framework of the "1st Call for proposals for research projects for the support of Faculty members and Researchers working in the Greek Universities and Research Centers and the procurement of strategic research equipment.
SUPPORT OF YOUNG RESEARCHERS – CALL Β’, ESPA 2014-2020 The National Hellenic Research Foundation, in the framework of the above Action, implements the project "Aqueous Asymmetric Homogeneous Catalysis" (YDAK) which has been designed to improve the innovative research in topics of transition-metal catalysis, and in particular aqueous and asymmetric catalysis. The aim of the intervention is to strengthen the academic curriculum vitae of young researchers and their research skills, in order to improve the prospects of their academic/research career.
“RESEARCH-CREATE-INNOVATE” The National Hellenic Research Foundation currently participates in the research project NEOVIOPRO for the identification of biomarkers in prostate cancer. The identification of prognostic biomarkers of the clinical course of the disease, as well as of predictive biomarkers of the response to a therapeutic approach, constitutes the subject of investigation and aims at a timely and more effective treatment of the disease.
“RESEARCH-CREATE-INNOVATE” RIS3 "AGROFOOD" Unlike other vegetable oils, olive oil has a high content of high-quality fatty acids suitable for the infant. This makes it ideal for use as a raw material in infant formula. ELAION project aims for the first time, to utilize olive oil in infant formulas in a pilot scale infant formula production unit in the Region of Western Greece.
“RESEARCH-CREATE-INNOVATE” CO2 BioProducts project aims at the systematic exploitation of the microalgal ability to produce a broad range of biochemical and bioactive high added-value ingredients which can be used by various industries, e.g. cosmetics and dietary products.
“RESEARCH CREATE-INNOVATE” Bioinspired antiageing proteasome activators RESET relies on the active collaboration between InterMed SA, and the Institute of Chemical Biology/NHRF
«RESEARCH-CREATE-INNOVATE» Health Span project, is based on the collaboration of Qualia Pharma S.A. with the National Hellenic Research Foundation (NHRF). The project aims to the development of a new dietary supplement, that will promote well-being and longevity.
Presentation of The good story of dogs who helped pharmacologists in the discovery of a new drug against Leishmaniasis. The New Medicines for Trypanosomatidic Infections (NMTrypI) 2014-2017. GA603240. FP7 European project presents the video about the dog trial performed during the project implementation: (dog trial of NMT-A2) and its 2 years follow-up after the project end (2018-2019).
Special Issue: Transition Metal Catalyzed Cross-Coupling Reactions (Catalysts) Invitation to submit // Deadline for manuscript submissions: 31 December 2019
“RESEARCH-CREATE-INNOVATE” The National Hellenic Research Foundation coordinates the QFytoTera research consortium in the effort to develop innovative repellent products that prevent spread of insect-borne diseases
Press Release Dr. Georgios Skretas is awarded a Consolidator Grant from the European Research Council (ERC) to develop engineered bacteria that accelerate drug discovery against diseases caused by protein misfolding.
Press Release 14 Early Stage Researchers (Marie-Curie Fellows) to be trained in a European training network for the discovery of small molecule neurotrophin mimetics as candidate therapeutic agents for neurodegeneration and neuro-inflammation.
Press Release Double honorary distinction for the collaboration of the National Hellenic Research Foundation with the Harvard University Medical School
Pre-call for PhD and Post-Doc Research Positions The Biomimetics and Nanobiotechnology team of the Institute of Biology, Medicinal Chemistry & Biotechnology, NHRF, is inviting young fellows with a) Msc diploma and b) PhD in Chemistry, Biology, Chemical Engineering, Biotechnology or relevant to express their interest in carrying out: a) PhD or b) Post-doctoral research in the research field of Bioactive compounds isolation from culture growth medium and their protection via nanoencapsulation
Exploratory call for expression of interest / New fellows in cancer research
PRESS RELEASE Engineered bugs for the discovery of new drugs
"BIOENTREPRENEURSHIP" Post-graduate Programme // Call for Applications (Academic period 2017-2018) | CALL FOR APPLICATIONS |
Άρθρο της εφημερίδος ΒΗΜΑ για τη συνεργασία του Εθνικού Ιδρύματος Ερευνών με την Ιατρική Σχολή Αθηνών Σε άρθρο της εφημερίδος ΒΗΜΑ της 15-16/4/2017 παρουσιάζονται τα αποτελέσματα της συνεργασίας της ερευνητικής ομάδος του Δρ. Βασίλη Λ. Σουλιώτη, Διευθυντή Ερευνών στο Ινστιτούτο Βιολογίας, Φαρμακευτικής Χημείας και Βιοτεχνολογίας του Εθνικού Ιδρύματος Ερευνών με την Θεραπευτική Κλινική της Ιατρικής Σχολής Αθηνών (Διευθυντής Καθ. Μελέτιος-Αθανάσιος Δημόπουλος) και τη Μονάδα Ρευματολογίας-Ανοσολογίας της Α΄ Προπαιδευτικής Παθολογικής Κλινικής της Ιατρικής Σχολής Αθηνών (Διευθυντής Καθ. Πέτρος Π Σφηκάκης).
PRESS RELEASE Unraveling the drug-resistance mechanisms in tumor cells
Workshop on Targeted Drug Discovery // October 10-14 2016, National Hellenic Research Foundation | POSTER |
"BIOENTREPRENEURSHIP" Post-graduate Programme // Call for Applications (Academic period 2016-2017) | CALL FOR APPLICATIONS | POSTER |
Study performed by IBMCB/NHRF groups is awarded in the 1st International Conference on Pharmaceutical Bioinformatics
Workshop: "Dilemmas in structural biology: selection and integration of methods" National Hellenic Research Foundation (NHRF) Athens, Greece 14-17 February 2016
FEBS/IUBMB Advanced Lecture Course "Molecular basis of human diseases: 50 years anniversary of Spetses summer schools" Abstract submissions and Fellowship applications will be accepted until 29.02.2016 27.05.2015-01.06.2016 // Spetses island, Greece
IUBMB/IUPAB/IUPS Joint Advanced School "Receptors and signaling" Abstract submissions and Fellowship applications will be accepted until 14.03.2016 23-27.05.2016, Spetses island, Greece
"BIOENTREPRENEURSHIP": A New Interinstitutional Post-graduate Programme The Post-graduate Programme "BIOENTREPRENEURSHIP" is organised by the Department of Biochemistry & Biotechnology of the University of Thessaly and the Institute of Biology, Medicinal Chemistry & Biotechnology of the National Hellenic Research Foundation. Visit the BIOENTREPRENEURSHIP website at: http://bioepixirin.bio.uth.gr/
Argyro Kalaitzaki, the first Ph.D. from the Orebro University - NHRF
Phenotypic Ontologies An ontology of phenotypic qualities, intended for use in a number of applications, primarily defining composite phenotypes and phenotype annotation
Infrastructure the Institute has recently acquired state-of-the-art scientific instrumentation and it can be considered one of the best equipped research institutes in Greece in the fields of Nuclear Magnetic Resonance, Mass spectroscopy and X-ray Protein Crystallography
INSTRUCT-EL Integrated Structural Biology for Europe - Hellenic subgroup
